Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases
Abstract Neural stem cells (NSCs) have increasingly been recognized as the most promising candidates for cell-based therapies for the central nervous system (CNS) injuries, primarily due to their pluripotent differentiation capabilities, as well as their remarkable secretory and homing properties. I...
Saved in:
| Main Authors: | Xiangwen Tang, Peng Deng, Lin Li, Yuqing He, Jinchao Wang, Dingjun Hao, Hao Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-024-04089-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem cells use in the treatment of neurologic disorders: Has the future already arrived?
by: Obradović Dragana, et al.
Published: (2008-01-01) -
Human induced pluripotent stem cell–derived therapies for regeneration after central nervous system injury
by: Stephen Vidman, et al.
Published: (2025-11-01) -
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma
by: Shu Wang, et al.
Published: (2025-02-01) -
Central nervous system relapse of an extranodal natural killer/T‐cell lymphoma
by: Radu Chiriac, et al.
Published: (2024-10-01) -
Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01)